Olaparib Intermediate: Synthesis and Application of 2-Fluoro-5-u00ad[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoic Acid
Discover the critical role of 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid as a key building block in the synthesis of Olaparib, a groundbreaking PARP inhibitor for cancer treatment. As a leading pharmaceutical intermediate manufacturer in China, we provide high-purity compounds essential for drug development.
Get a Quote & SampleProduct Core Value
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
This compound is a vital intermediate in the pharmaceutical industry, primarily used in the synthesis of Olaparib. Olaparib is a potent poly(ADP-ribose) polymerase (PARP) inhibitor, a class of drugs demonstrating significant efficacy in treating various cancers. Our commitment as a reliable supplier in China ensures the availability of this high-quality intermediate, manufactured with precision to meet stringent pharmaceutical standards.
- The synthesis of 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid involves complex organic reactions, requiring specialized expertise in pharmaceutical intermediate manufacturing.
- We are dedicated to providing high-purity intermediates, ensuring optimal performance in the downstream production of Olaparib, supporting crucial anticancer drug development.
- Understanding the precise chemical synthesis pathways is key to efficiently producing Olaparib intermediate, contributing to the broader field of oncology treatments.
- Sourcing high-quality pharmaceutical intermediates is paramount for drug efficacy and safety; we are a trusted partner for your chemical synthesis needs.
Key Advantages Offered
High Purity Assurance
Our 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid is guaranteed to have a purity of u226598%, ensuring reliable and consistent results in your Olaparib synthesis, crucial for effective anticancer drug development.
Critical Role in Olaparib Synthesis
As a specialized manufacturer in China, we supply this essential building block for Olaparib, a leading PARP inhibitor. Its availability facilitates the efficient production of life-saving cancer therapies.
Reliable Pharmaceutical Sourcing
We focus on providing stable supply chains for pharmaceutical intermediates. Partnering with us means accessing a dependable source for critical components in your manufacturing processes, supporting your efforts in anticancer drug development.
Key Applications
Olaparib Synthesis
This compound is a direct precursor for Olaparib, a targeted therapy for specific types of cancer. Its purity directly impacts the quality of the final API.
PARP Inhibitor Development
Beyond Olaparib, it serves as a versatile intermediate for the research and development of other Poly(ADP-ribose) Polymerase (PARP) inhibitors, expanding therapeutic options in oncology.
Pharmaceutical Intermediate Manufacturing
Used as a fine chemical intermediate in the broader pharmaceutical industry, supporting the synthesis of complex molecules and APIs.
Oncology Research
Essential for academic and industrial research focused on developing novel treatments for cancer, particularly those involving DNA repair pathways.